cefazolin sodium salt  (Tokyo Chemical Industry)

Journal: Frontiers in Microbiology

Article Title: The effect of elevated physiological temperatures on bacterial survival and antibiotic susceptibility in an in vitro infection prevention model

doi: 10.3389/fmicb.2026.1830056

Figure Lengend Snippet: Remaining bacteria titres for S. aureus with cefazolin after 24 h of culture at different antibiotic concentrations and ambient temperatures. Concentrations are in μg/mL. Results are reported as log(CFU/mL) ± 95% CI.

Article Snippet: Cefazolin (solid powder, Mylan, U.K.), was used at concentrations of 0.05, 0.1, 0.25 and 0.5 μg/mL for S. aureus and S. epidermidis and 0.1, 0.5 and 1 μg/mL for E. coli .

Techniques: Bacteria

Journal: Frontiers in Microbiology

Article Title: The effect of elevated physiological temperatures on bacterial survival and antibiotic susceptibility in an in vitro infection prevention model

doi: 10.3389/fmicb.2026.1830056

Figure Lengend Snippet: Calculated log-logistic curves for the planktonic (A) and adherent (B) fractions of S. aureus with cefazolin.

Article Snippet: Cefazolin (solid powder, Mylan, U.K.), was used at concentrations of 0.05, 0.1, 0.25 and 0.5 μg/mL for S. aureus and S. epidermidis and 0.1, 0.5 and 1 μg/mL for E. coli .

Techniques:

Journal: Frontiers in Microbiology

Article Title: The effect of elevated physiological temperatures on bacterial survival and antibiotic susceptibility in an in vitro infection prevention model

doi: 10.3389/fmicb.2026.1830056

Figure Lengend Snippet: Remaining bacteria titres for S. epidermidis with cefazolin after 24 h of culture at different antibiotic concentrations and ambient temperatures. Concentrations are in μg/mL. Results are reported as log(CFU/mL) ± 95% CI.

Article Snippet: Cefazolin (solid powder, Mylan, U.K.), was used at concentrations of 0.05, 0.1, 0.25 and 0.5 μg/mL for S. aureus and S. epidermidis and 0.1, 0.5 and 1 μg/mL for E. coli .

Techniques: Bacteria

Journal: Frontiers in Microbiology

Article Title: The effect of elevated physiological temperatures on bacterial survival and antibiotic susceptibility in an in vitro infection prevention model

doi: 10.3389/fmicb.2026.1830056

Figure Lengend Snippet: Calculated log-logistic curves for the planktonic (A) and adherent (B) fractions of S. epidermidis with cefazolin.

Article Snippet: Cefazolin (solid powder, Mylan, U.K.), was used at concentrations of 0.05, 0.1, 0.25 and 0.5 μg/mL for S. aureus and S. epidermidis and 0.1, 0.5 and 1 μg/mL for E. coli .

Techniques:

Journal: Frontiers in Microbiology

Article Title: The effect of elevated physiological temperatures on bacterial survival and antibiotic susceptibility in an in vitro infection prevention model

doi: 10.3389/fmicb.2026.1830056

Figure Lengend Snippet: Remaining bacteria titres for E. coli with cefazolin after 24 h of culture at different antibiotic concentrations and ambient temperatures. Concentrations are in μg/mL. Results are reported as log(CFU/mL) ± 95% CI.

Article Snippet: Cefazolin (solid powder, Mylan, U.K.), was used at concentrations of 0.05, 0.1, 0.25 and 0.5 μg/mL for S. aureus and S. epidermidis and 0.1, 0.5 and 1 μg/mL for E. coli .

Techniques: Bacteria

Journal: Frontiers in Microbiology

Article Title: The effect of elevated physiological temperatures on bacterial survival and antibiotic susceptibility in an in vitro infection prevention model

doi: 10.3389/fmicb.2026.1830056

Figure Lengend Snippet: Calculated log-logistic curves for the planktonic (A) and adherent (B) fractions of E. coli with cefazolin.

Article Snippet: Cefazolin (solid powder, Mylan, U.K.), was used at concentrations of 0.05, 0.1, 0.25 and 0.5 μg/mL for S. aureus and S. epidermidis and 0.1, 0.5 and 1 μg/mL for E. coli .

Techniques: